First CRISPR treatment for sickle cell, other blood disease shows early benefits in two patients
The first two patients to receive a CRISPR-based treatment for the inherited blood disorders sickle cell disease and beta thalassemia have benefited from the experimental therapy and experienced only temporary and treatable side effects.
Doctors use CRISPR gene editing against cancer for the 1st time in the U.S.
Doctors were able to take immune system cells from the patients' blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects.
CRISPR gene-editing ‘eliminates’ HIV in some mice. What does it mean for humans?
Antiretroviral therapy is the standard HIV treatment, but patients are never rid of the virus. A new study raises the possibility of HIV elimination through gene-editing with CRISPR.
‘Jumping genes’ could help CRISPR replace disease-causing DNA, study finds
Researchers describe combining a "jumping gene" with CRISPR enzymes to deliver a a package of DNA to precise addresses in the E. coli genome.
Gene-editing with CRISPR reveals why snail shells are asymmetrical and coil either left or right.
The apparent birth this month of the first genetically modified babies is “a lesson in the potential for human hubris to overtake us,” Dr. Francis Collins, the director of the National Institutes of Health.
The DNA damage found in the new study included deletions of thousands of DNA bases, including at spots far from the edit. Some of the deletions can silence genes that should be active and activate genes that should be silent,…
For the first time, U.S. scientists have genetically edited human embryos with CRISPR, thanks in part to regulatory loopholes.
Additional Support Provided By:
